WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke CLARAVA wurde als Wortmarke am 03.09.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1621013 |
| Länder | 
|
| Basismarke |
Nr. 90563233,
05. März 2021
|
| Anmeldedatum | 03. September 2021 |
| Ablaufdatum | 03. September 2031 |
Markeninhaber
Avon House, 19 Stanwell Road
Panarth, Cardiff CF642EZ
GB
Panarth, Cardiff CF642EZ
GB
Markenvertreter
1299 Pennsylvania Avenue, NW,
Suite 700
US
Waren und Dienstleistungen
05
Medical diagnostic blood or biopsy testing reagents and
assays for advanced next-generation sequencing science for
creating immune profiling of kidney transplant recipients
for predicting and identifying risk of graft rejection;
medical diagnostic reagents consisting primarily of reagents
for use in disease testing and prediction; nucleic acid
sequences and chemical reagents for medical purposes
10
Blood test collection kit comprised of blood collection tube
and bag, and holder for medical sample tubes, for predicting
and identifying the risk of graft injury and graft loss in
kidney transplant recipients
42
Development of new technology for others in the field of
medical devices and medical diagnostic apparatuses;
research, development and consultation related thereto in
the field of medical devices and medical diagnostic
apparatuses through the use of artificial intelligence;
laboratory research in the field of kidney transplant;
medical research services; computer software development;
providing temporary use of on-line non-downloadable software
and software applications using artificial intelligence for
medical analysis
44
Medical profile and medical record analysis designed to
provide patients with custom tailored information about the
range of possible diagnoses and therapies associated with a
defined set of symptoms; medical analysis services for
predicting and identifying risk of graft rejection in kidney
transplant patients
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 13. Juli 2023 | 2023/29 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 28. Februar 2023 | 2023/11 Gaz | CN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 30. Januar 2023 | 2023/5 Gaz | CA | Ablehnung |
| 06. Dezember 2022 | 2022/49 Gaz | KR | Ablehnung |
| 26. Oktober 2022 | 2022/43 Gaz | BR | Ablehnung |
| 26. September 2022 | 2022/39 Gaz | IN | Ablehnung |
| 23. September 2022 | 2022/38 Gaz | NO | Ablehnung |
| 01. September 2022 | 2022/35 Gaz | CH | Ablehnung |
| 22. August 2022 | 2022/34 Gaz | MX | Ablehnung |
| 19. August 2022 | 2022/33 Gaz | JP | Ablehnung |
| 18. Juli 2022 | 2022/30 Gaz | EM | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 11. Juni 2022 | 2022/24 Gaz | GB | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 02. Juni 2022 | 2022/22 Gaz | IL | Ablehnung |
| 24. Mai 2022 | 2022/22 Gaz | EM | Ablehnung |
| 16. Mai 2022 | 2022/22 Gaz | RAW: Limitation | |
| 21. April 2022 | 2022/18 Gaz | CN | Ablehnung |
| 20. April 2022 | 2022/16 Gaz | SG | Ablehnung |
| 09. April 2022 | 2022/17 Gaz | GB | Ablehnung |
| 25. März 2022 | 2022/12 Gaz | NZ | Ablehnung |
| 17. Februar 2022 | 2022/8 Gaz | CN | Ablehnung |
| 31. Januar 2022 | 2022/5 Gaz | RU | Ablehnung |
| 12. Januar 2022 | 2022/2 Gaz | AU | Ablehnung |
| 03. September 2021 | 2021/40 Gaz | US | Eintragung |
ID: 141621013